# Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy

> **NCT00694863** · PHASE2 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Idiopathic Membranous Nephropathy

## Interventions

- **DRUG:** tetracosactide hexacetaat

## Key facts

- **NCT ID:** NCT00694863
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-12
- **Final completion:** 2012-12
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-01-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694863, "Treatment With Synthetic ACTH in High Risk Patients With Membranous Nephropathy". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00694863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*